Search Results - "Šimůnek, T"

Refine Results
  1. 1

    Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone by Šimůnek, T, Štěrba, M, Popelová, O, Kaiserová, H, Adamcová, M, Hroch, M, Hašková, P, Poňka, P, Geršl, V

    Published in British journal of pharmacology (01-09-2008)
    “…Background and purpose: The clinical utility of anthracycline antineoplastic drugs is limited by the risk of cardiotoxicity, which has been traditionally…”
    Get full text
    Journal Article
  2. 2

    Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death by Popelová, O, Štěrba, M, Hašková, P, Šimůnek, T, Hroch, M, Gunčová, I, Nachtigal, P, Adamcová, M, Geršl, V, Mazurová, Y

    Published in British journal of cancer (01-09-2009)
    “…Background: Dexrazoxane (DEX, ICRF-187) is the only clinically approved cardioprotectant against anthracycline cardiotoxicity. It has been traditionally…”
    Get full text
    Journal Article
  3. 3

    Iron is not involved in oxidative stress‐mediated cytotoxicity of doxorubicin and bleomycin by Kaiserová, H, Hartog, G J M, Šimůnek, T, Schröterová, L, Kvasničková, E, Bast, A

    Published in British journal of pharmacology (01-12-2006)
    “…Background and purpose: The anticancer drugs doxorubicin and bleomycin are well‐known for their oxidative stress‐mediated side effects in heart and lung,…”
    Get full text
    Journal Article
  4. 4

    Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination by Sterba, M, Simůnek, T, Popelová, O, Potácová, A, Adamcová, M, Mazurová, Y, Holecková, M, Gersl, V

    Published in Physiological research (01-01-2007)
    “…Anthracycline cardiotoxicity represents a serious risk of anticancer chemotherapy. The aim of the present pilot study was to compare the potential of both the…”
    Get full text
    Journal Article
  5. 5

    Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents by Potácová, A, Adamcová, M, Cajnáková, H, Hrbatová, L, Sterba, M, Popelová, O, Simůnek, T, Ponka, P, Gersl, V

    Published in Physiological research (01-01-2007)
    “…The aim of this study was to analyze the ECG time intervals in the course of the development of chronic anthracycline cardiomyopathy in rabbits. Furthermore,…”
    Get full text
    Journal Article
  6. 6

    Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits by Šimůnek, T., Klimtová, I., Kaplanová, J., Štěrba, M., Mazurová, Y., Adamcová, M., Hrdina, R., Geršl, V., Poňka, P.

    Published in Pharmacological research (01-03-2005)
    “…Risk of cardiotoxicity is the most serious drawback of the clinical usefulness of anthracycline antineoplastic antibiotics, which however, remain among the…”
    Get full text
    Journal Article
  7. 7

    Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits by Sterba, M, Simůnek, T, Mazurová, Y, Adamcová, M, Popelová, O, Kaplanova, J, Ponka, P, Gersl, V

    Published in Human & experimental toxicology (01-11-2005)
    “…Recently, pyridoxal 2-chlorobenzoyl hydrazone (o-108) has been identified as an effective iron chelator [Link et al., Blood 2003; 101: 4172-79]. Since chronic…”
    Get more information
    Journal Article
  8. 8

    Anthracycline-induced cardiotoxicity by Hrdina, R, Gersl, V, Klimtová, I, Simůnek, T, Machácková, J, Adamcová, M

    “…Anthracycline antibiotics are among the most effective and widely used antineoplastic drugs. Their usefulness is limited by a cumulative dose-related…”
    Get full text
    Journal Article
  9. 9

    Cardiac troponin T following repeated administration of pyridoxal isonicotinoyl hydrazone in rabbits by Adamcová, M, Machácková, J, Gersl, V, Pelouch, V, Simůnek, T, Klimtová, I, Hrdina, R, Ponka, P

    Published in Physiological research (2002)
    “…Pyridoxal isonicotinoyl hydrazone (PIH) is a new tridentate Fe-chelating agent that should be very promising in many pathological states resulting from both an…”
    Get full text
    Journal Article
  10. 10

    Protein profiling in daunorubicin-induced cardiomyopathy by Adamcová, M, Pelouch, V, Gersl, V, Kaplanová, J, Mazurová, Y, Simůnek, T, Klimtová, I, Hrdina, R

    Published in General physiology and biophysics (01-09-2003)
    “…The aim of this paper was to study the protein remodelling of the left ventricle following repeated administration of either daunorubicin (DNR) or DNR in…”
    Get full text
    Journal Article
  11. 11

    The role of reactive oxygen and nitrogen species in cellular iron metabolism by Mladenka, Premysl, Simůnek, Tomás, Hübl, Mojmír, Hrdina, Radomír

    Published in Free radical research (01-03-2006)
    “…The catalytic role of iron in the Haber-Weiss chemistry, which results in propagation of damaging reactive oxygen species (ROS), is well established. In this…”
    Get more information
    Journal Article
  12. 12

    In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity by ADAMCOVA, Michaela, SIMUNEK, Tomas, KAISEROVA, Helena, POPELOVA, Olga, STERBA, Martin, POTACOVA, Anna, VAVROVA, Jaroslava, MALAKOVA, Jana, GERSL, Vladimir

    Published in Toxicology (Amsterdam) (31-07-2007)
    “…Abstract Cardiac troponin T (cTnT) and troponin I (cTnI) are becoming acknowledged as useful biochemical markers of drug-induced cardiotoxicity. In this study…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents by Šimůnek, Tomáš, Klimtová, Ivona, Kaplanová, Jana, Mazurová, Yvona, Adamcová, Michaela, Štěrba, Martin, Hrdina, Radomír, Geršl, Vladimír

    Published in European journal of heart failure (01-06-2004)
    “…Background: Cardiac toxicity associated with chronic administration of anthracycline (ANT) antibiotics represents a serious complication of their use in…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Direct administration of rutin does not protect against catecholamine cardiotoxicity by Mladěnka, Přemysl, Zatloukalová, Libuše, Šimůnek, Tomáš, Bobrovová, Zuzana, Semecký, Vladimír, Nachtigal, Petr, Hašková, Pavlína, Macková, Eliška, Vávrová, Jaroslava, Holečková, Magdaléna, Palicka, Vladimir, Hrdina, Radomír

    Published in Toxicology (Amsterdam) (08-01-2009)
    “…Abstract High levels of catecholamines are cardiotoxic and may trigger acute myocardial infarction (AMI). Similarly, the synthetic catecholamine isoprenaline…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    New iron chelators in anthracycline-induced cardiotoxicity by Kaiserová, Helena, Simunek, Tomás, Sterba, Martin, den Hartog, Gertjan J M, Schröterová, Ladislava, Popelová, Olga, Gersl, Vladimír, Kvasnicková, Eva, Bast, Aalt

    Published in Cardiovascular toxicology (01-06-2007)
    “…The use of anthracycline anticancer drugs is limited by a cumulative, dose-dependent cardiac toxicity. Iron chelation has long been considered as a promising…”
    Get full text
    Journal Article